In pancreatic cancer, the activation of tumor-associated macrophage (TAM) Dectin-1 promotes the M2 polarization of TAMs, inhibiting T cell immunity and thus facilitating tumor progression. The gene discussed is CLEC7A; the disease is neoplasm.